Current Formulations Profile
Key Indicators
- Authorised Capital ₹ 1.20 M
- Paid Up Capital ₹ 0.80 M
- Company Age 42 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 12.10 Cr
- Revenue Growth 20.33%
- Profit Growth 27.59%
- Ebitda -21.52%
- Net Worth 28.88%
- Total Assets 52.08%
About Current Formulations
Current Formulations Private Limited (CFPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 February 1982 and has a history of 42 years and 11 months. Its registered office is in Pondicherry, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.20 M and a paid-up capital of Rs 0.80 M.
The company has closed loans amounting to ₹12.10 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Agillavadivu Visweswaran and Visweswaran Malaikkolundumudaliar serve as directors at the Company.
Company Details
-
Location
Pondicherry, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24239PY1982PTC000190
-
Company No.
000190
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
19 Feb 1982
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Pondicherry
Industry
Who are the key members and board of directors at Current Formulations?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Agillavadivu Visweswaran
|
Director | 20-Aug-2010 | Current |
|
Visweswaran Malaikkolundumudaliar
|
Director | 20-Aug-2010 | Current |
Financial Performance of Current Formulations.
Current Formulations Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 20.33% increase. The company also saw a substantial improvement in profitability, with a 27.59% increase in profit. The company's net worth Soared by an impressive increase of 28.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Current Formulations?
Unlock access to Current Formulations's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹0
₹121.00 M
Charges Breakdown by Lending Institutions
- Karnataka Bank Limited : 12.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Apr 2005 | Karnataka Bank Limited | ₹12.10 Cr | Satisfied |
How Many Employees Work at Current Formulations?
Unlock and access historical data on people associated with Current Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Current Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Current Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
